iRhythm Technologies, Inc.

NASDAQ:IRTC

Medical - Devices

Healthcare
$94.87 +0.35%

+$0.36 today

Market cap
$3.19B
Beta
1.28
P/E (TTM)
-119.5
EPS (TTM)
-$0.85
52W Low $100.85High $212.00

Volume 1.20M

Average 0.52M

IRTC Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

iRhythm Technologies, Inc.NASDAQ: IRTC

Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026

Cost of revenue grows, but more slowly than its trailing trend

Q3 FY2026 cost of revenue of $57.1M rose 2.4% year over year, behind the +13.7% change in trailing-twelve-month cost of revenue. Sequentially, it fell 6.3% from the prior quarter. Over 3 fiscal years it compounded at +19.4% a year.

Context

  • Cost of revenue amounted to 29.4% of revenue in FY2025, down 1.7 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +2.4% toward the trailing-twelve-month pace of +13.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$57.1M-6.3% QoQ
Last fiscal yearDec 2025
$219.89M+19.3% YoY
LTMSep 2026
$236.94M+13.7% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.4%——
1 year+19.3%——
3-year CAGR+19.4%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
219.89M USD
Year-over-year change
+19.3%
4-year CAGR
+19.1%

Cost of Revenue vs competitors

How IRTC compares with its peers on the latest reported figures

  • IRTC's LTM Sep 2026 cost of revenue of $236.94M is the 5th highest of the 7 companies compared; the peer median is $483.73M.
  • Its year-over-year change of +13.7% is the 3rd highest of 7, against a peer median of +10.1%.
  • Cost of revenue amounts to 27.7% of revenue for IRTC, versus a peer median of 32.1%.
IRTC Competitors Peer median
Cost of Revenue for IRTC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$12.51B +0.0%+5.9%33.3%
BSXBoston Scientific CorporationLTM Jun 2026$6.06B -11.0%+7.8%28.8%
PENPenumbra, Inc.LTM Jun 2026$483.98M +12.8%+13.9%32.2%
LIVNLivaNova PLCLTM Sep 2026$483.49M +13.8%+12.5%32.1%
IRTCiRhythm Technologies, Inc.LTM Sep 2026$236.94M +13.7%+19.4%27.7%
ATRCAtriCure, Inc.LTM Jun 2026$135.77M +7.4%+17.4%23.8%
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026$42.91M +23.8%—51.2%
Peer median (excluding IRTC) $483.73M+10.1%+12.5%32.1%

Competitors are the stored peer set for IRTC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue322.83M410.92M492.68M591.84M747.14M
Cost of Revenue109.26M129.29M160.88M184.31M219.89M
Gross Profit213.57M281.63M331.81M407.53M527.25M
Gross Margin66.2%68.5%67.3%68.9%70.6%
Research & Development38.67M46.61M60.24M103.83M84.61M
Selling, General & Admin274.84M322.2M385.65M418.57M479.45M
Operating Expenses313.51M395.42M456.97M523.04M564.06M
Depreciation & Amortization16.59M19.61M22.14M25.78M26.48M
EBITDA(83.23M)(92.14M)(96.86M)(74.13M)(3.97M)
EBITDA Margin-25.8%-22.4%-19.7%-12.5%-0.5%
Operating Income(99.94M)(113.78M)(125.16M)(115.51M)(36.81M)
Operating Margin-31.0%-27.7%-25.4%-19.5%-4.9%
Interest Income118K2.35M6.16M21.94M21.52M
Interest Expense1.17M4.14M3.65M12.82M13.15M
Other Income / Expenses(1.05M)(2.1M)2.51M2.78M(6.79M)
Income Before Tax(100.99M)(115.89M)(122.66M)(112.72M)(43.6M)
Pre-Tax Margin-31.3%-28.2%-24.9%-19.0%-5.8%
Income Tax Expense367K269K750K565K953K
Net Income(101.36M)(116.16M)(123.41M)(113.29M)(44.55M)
Net Margin-31.4%-28.3%-25.0%-19.1%-6.0%
EPS (Basic)(3.46)(3.88)(4.04)(3.63)(1.39)
EPS (Diluted)(3.46)(3.88)(4.04)(3.63)(1.39)
Weighted Avg Shares29.33M29.92M30.53M31.2M32M
Weighted Avg Shares (Diluted)29.33M29.92M30.53M31.2M32M

iRhythm Technologies, Inc.

NASDAQ:IRTC

Intrinsic Alpha fair value

Locked

Current Price

$94.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.